戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in treating primary biliary cholangitis, an autoimmune liver disease.
2 pite its classification as a T cell-mediated autoimmune liver disease.
3 responses during hepatotropic infections and autoimmune liver disease.
4 clinical implication of this autoantibody in autoimmune liver disease.
5 with 242 patients with conventional forms of autoimmune liver disease.
6  were included from the Canadian Network for Autoimmune Liver Disease.
7  cholangitis (PBC) is a chronic, progressive autoimmune liver disease.
8 logic mechanisms of the pathogenesis of this autoimmune liver disease.
9 store immune homeostasis in inflammatory and autoimmune liver disease.
10 uld lead to novel treatment targets in human autoimmune liver diseases.
11 gents might be developed as therapeutics for autoimmune liver diseases.
12 ral hepatitis, cholestatic liver disease and autoimmune liver diseases.
13 ds breakdown in hepatic tolerance leading to autoimmune liver diseases.
14  to develop curative immune based therapy in autoimmune liver diseases.
15 and in particular on three dominant SCFAs in autoimmune liver diseases.
16 ities such as Black and Latinx patients with autoimmune liver diseases.
17 e factors contributing to health inequity in autoimmune liver diseases.
18 ment of new therapies for people living with autoimmune liver diseases.
19 Ulcerative colitis (1.40[1.34-1.46], RD0.1), Autoimmune liver disease (1.32[1.21-1.43], RD0.01), and
20 frequency and nature of variant syndromes in autoimmune liver disease, 162 patients with type 1 autoi
21                                           In autoimmune liver disease, activation of the hepatocyte I
22  a radioligand assay (RLA), 81 patients with autoimmune liver disease (AILD) (33 type 1 AIH, 31 type
23        We have investigated 51 patients with autoimmune liver disease (AILD) and 27 healthy subjects,
24 ) impairment has been previously reported in autoimmune liver disease (AILD; including autoimmune hep
25                                              Autoimmune liver diseases (AILD) are increasing and comm
26                                              Autoimmune liver diseases (AILD) are rare diseases with
27                                              Autoimmune liver diseases (AILD) involve dysregulated CD
28                                              Autoimmune liver diseases (AILDs) are associated with sy
29 iving donor liver transplantation (LDLT) for autoimmune liver diseases (AILDs) is scarce.
30 nt with anti-IL-6R if they have accompanying autoimmune liver disease and emphasize caution for thera
31                       Females developed more autoimmune liver disease and greater titers of anti-DNA
32  Primary biliary cholangitis (PBC) is a rare autoimmune liver disease and the first line available tr
33 g at the DR and A loci affects recurrence of autoimmune liver diseases and hepatitis C, respectively.
34     Clinical management of Wilson's disease, autoimmune liver disease, and chronic biliary disorders,
35 ary cholangitis (PBC), a chronic cholestatic autoimmune liver disease, and the peripheral immune syst
36                   In conclusion, variants of autoimmune liver disease are common.
37                                          All autoimmune liver diseases are associated with reduced di
38                                              Autoimmune liver diseases are attributed to a complex in
39                                     Overall, autoimmune liver diseases are characterized by an altere
40  is poorly understood, PSC is regarded as an autoimmune liver disease based on a strong immunogenetic
41 y biliary cholangitis (PBC) is a cholestatic autoimmune liver disease characterized by autoreactive T
42        Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by destruction of
43        Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by destruction of
44 imary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by progressive bi
45      Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by the destructio
46 biliary cirrhosis (PBC) is an organ-specific autoimmune liver disease characterized by the presence o
47        Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by the presence o
48        Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by the presence o
49 imary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodul
50   Primary biliary cirrhosis (PBC), a chronic autoimmune liver disease, has been associated with incre
51 ought that an infectious agent triggers this autoimmune liver disease in genetically predisposed indi
52 eatment response, and outcomes pertaining to autoimmune liver diseases in minority populations, on th
53                                              Autoimmune liver diseases include primary biliary cholan
54                              The etiology of autoimmune liver disease is poorly understood.
55 ns in clinical phenotype and outcome for the autoimmune liver diseases may reflect host-specific and
56  mechanisms underlies the pathophysiology of autoimmune liver diseases, nonalcoholic steatohepatitis,
57    Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease of unknown etiology.
58 , alcohol-associated liver disease (ALD), or autoimmune liver disease/other using validated case defi
59                                              Autoimmune liver diseases persist despite high frequenci
60                                              Autoimmune liver diseases predominantly affect women.
61               A unique characteristic of the autoimmune liver disease primary biliary cirrhosis (PBC)
62                                          The autoimmune liver disease primary biliary cirrhosis (PBC)
63                                          The autoimmune liver disease primary biliary cirrhosis (PBC)
64 ression that the number of patients with the autoimmune liver disease primary biliary cirrhosis (PBC)
65 munological event in the pathogenesis of the autoimmune liver disease primary biliary cirrhosis is br
66     Given the strong association between the autoimmune liver diseases primary sclerosing cholangitis
67                                 Unlike other autoimmune liver diseases, primary biliary cirrhosis (PB
68 robiome are initiating or driving factors in autoimmune liver diseases, secondary consequences of dis
69                 Study of the pathogenesis of autoimmune liver diseases, such as autoimmune hepatitis
70 o host physiology, potentially linking it to autoimmune liver diseases, such as autoimmune hepatitis,
71  cholangitis (PBC) is a chronic, progressive autoimmune liver disease that mainly affects middle-aged
72            Primary biliary cholangitis is an autoimmune liver disease that predominantly affects wome
73 ugh the description of the three most common autoimmune liver diseases, the autoimmune reaction again
74 the MEDLINE search included the names of all autoimmune liver diseases, viral hepatitis and autoimmun
75 ary biliary cirrhosis (PBC) is a progressive autoimmune liver disease with a long natural history.
76      Primary biliary cholangitis (PBC) is an autoimmune liver disease with a strong hereditary compon
77 riant, autoimmune cholangitis, being the two autoimmune liver diseases with a predominance of IgM-pos
78 olangitis (ASC) are two very closely related autoimmune liver diseases with overlapping clinical feat
79 IgG may be helpful in distinguishing between autoimmune liver diseases, with primary biliary cirrhosi